Clinical Trials Directory

Trials / Completed

CompletedNCT05793632

Quetiapine in Prevention of Delirium

Role of Quetiapine in the Prevention of ICU Delirium in Elderly Patients at a High Risk

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The aim is to study the effectiveness of Quetiapine in preventing delirium in the elderly patients with multiple risks for delirium.

Conditions

Interventions

TypeNameDescription
DRUGQuetiapineThe patients will be randomly divided into two equal groups group Q and group C. Randomization will be done by computer-generated number lists and using opaque sealed envelopes.

Timeline

Start date
2023-03-01
Primary completion
2023-04-01
Completion
2023-04-15
First posted
2023-03-31
Last updated
2023-07-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05793632. Inclusion in this directory is not an endorsement.